Development of an app for individuals receiving in-centre hemodialysis

Study Lead

Dr. Stephanie Thompson & Dr. Clara Bohm

Overview

We are developing an app for people who are receiving in-centre hemodialysis. We are doing this in partnership with people receiving hemodialysis and their caregivers. The goal of the app is to help those receiving in-center hemodialysis live, feel, and be well. It will be “peer-to-peer”, which means we are collaborating with people living with kidney disease to make an app for people living with kidney disease.

We are looking for people like you or “patient partners” to co-create this app with us and provide input on content and presentation.

What is required of me?

The time commitment is approximately 4 hours per month. The role of a patient partner for this project is to collaborate with researchers about the content of the app and provide their personal insights or “patient pearls” about their experience that may be helpful for others. Communication will be primarily via virtual meetings and email. Patient partners will be provided with a gift card to reimburse the time provided.

This project is funded by Triple I (a Can-SOLVE CKD research project).

 

Eligibility

Adults (18+) receiving in-centre hemodialysis.

Type of Participation

Patient Partnership

Diagnosis

Chronic Kidney Disease

Treatment

Hemodialysis

Topic

Quality of Life

Location

All provinces and territories

Related studies

  • Promoting shared decision making for people with advanced chronic kidney disease

    Overview:

    Study type: Focus Group

    August 8, 2024

  • Improving the Care and Experiences of Living Kidney Donors

    Overview: Seeking family physicians and transplant healthcare professionals for an online interview that will help develop tools to improve the experiences, care, and outcomes of living kidney donors.

    Study type: Interview

    July 25, 2024

  • Phase 3 Pneumococcal Vaccine Study for Children & Adolescents at High Risk (STRIDE-13)

    Overview: STRIDE-13 is a pneumococcal vaccine research trial for children and adolescents with chronic disease (or chronic medical conditions).

    Study type: Clinical Trial

    July 11, 2024